Topiramate
Product Images NDC 52959-441

6 FDA label images from H.j. Harkins Company, Inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Topiramate (NDC 52959-441). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by H.j. Harkins Company, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label (Label1)

Label (Label1)
TOPIRAMATE 25mg TABLET label showing the lot number TOM00ZO, manufacturer TORRENT PH in Mehsana, India, and expiration date 11/10. The label displays the NDC number 52959-441-60 and identifies the pill as a white round tablet. It includes a comparison to TOPAMAX and instructions to follow doctor's directions or see the outer packaging for dosage information. Several smaller label copies are visible on the right side, repeating key details and manufacturer information.*
FDA Label Image

Label (Label2)

Label (Label2)
TOPIRAMATE 50 mg TABLET label displaying the lot number TMT00ZO, manufacturer TORRENT PH located in Mehsana, India, and expiration date 04/11. The label includes a comparison reference to TOPAMAX with manufacturer NDC 13668-032-05. It features dosage instructions advising to follow the doctor's directions or see the outer insert for dosage information. The label also contains multiple smaller repeat panels with similar product and manufacturing details.*
FDA Label Image

Image (Topiramate Figure 01)

Image (Topiramate Figure 01)
Chemical structure of the active ingredient Topiramate, showing its molecular connectivity including functional groups like sulfamate, ether, and multiple methyl substituents.*
FDA Label Image

Image (Topiramate Figure 02)

Image (Topiramate Figure 02)
A cumulative rate survival curve chart comparing time to first seizure for Topiramate at 50 mg/day and 400 mg/day doses over 500 days. The y-axis shows cumulative rates for time to first seizure, and the x-axis denotes time in days. Two lines represent the different dosage groups with sample sizes 234 and 236 respectively.*
FDA Label Image

Logo (Topiramate Figure 03)

FDA Label Image

Logo (Topiramate Figure 04)

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.